NCT00005965View on ClinicalTrials.gov

Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Study Completion Date

April 30, 2004

Conditions
Cervical Cancer
Interventions
DRUG

bryostatin 1

DRUG

cisplatin

Trial Locations (6)

10011

Saint Vincent Catholic Medical Center of New York, New York

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10021

New York Presbyterian Hospital - Cornell Campus, New York

10029

Mount Sinai Medical Center, NY, New York

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

10595

New York Medical College, Valhalla

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT00005965 - Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix | Biotech Hunter | Biotech Hunter